Global Nitinol-based Stent Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.
LPI (LP Information)' newest research report, the “Nitinol-based Stent Industry Forecast” looks at past sales and reviews total world Nitinol-based Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Nitinol-based Stent sales for 2023 through 2029. With Nitinol-based Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nitinol-based Stent industry.
This Insight Report provides a comprehensive analysis of the global Nitinol-based Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nitinol-based Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nitinol-based Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nitinol-based Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nitinol-based Stent.
The global Nitinol-based Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nitinol-based Stent players cover Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical and B. Braun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nitinol-based Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Nitinol-based Stent market?
What factors are driving Nitinol-based Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nitinol-based Stent market opportunities vary by end market size?
How does Nitinol-based Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.
LPI (LP Information)' newest research report, the “Nitinol-based Stent Industry Forecast” looks at past sales and reviews total world Nitinol-based Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Nitinol-based Stent sales for 2023 through 2029. With Nitinol-based Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nitinol-based Stent industry.
This Insight Report provides a comprehensive analysis of the global Nitinol-based Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nitinol-based Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nitinol-based Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nitinol-based Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nitinol-based Stent.
The global Nitinol-based Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nitinol-based Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nitinol-based Stent players cover Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, TERUMO, C. R. Bard, Cordis, Cook Medical and B. Braun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nitinol-based Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Bare-metal Stent (BMS)
- Drug-eluting Stent (DES)
- Hospital
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Edwards Lifesciences
- Abbott
- Boston Scientific
- TERUMO
- C. R. Bard
- Cordis
- Cook Medical
- B. Braun
- Biotronik
- Stryker
- JOTEC
- MicroPort
- Acandis
- ELLA-CS
What is the 10-year outlook for the global Nitinol-based Stent market?
What factors are driving Nitinol-based Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nitinol-based Stent market opportunities vary by end market size?
How does Nitinol-based Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nitinol-based Stent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nitinol-based Stent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nitinol-based Stent by Country/Region, 2018, 2022 & 2029
2.2 Nitinol-based Stent Segment by Type
2.2.1 Bare-metal Stent (BMS)
2.2.2 Drug-eluting Stent (DES)
2.3 Nitinol-based Stent Sales by Type
2.3.1 Global Nitinol-based Stent Sales Market Share by Type (2018-2023)
2.3.2 Global Nitinol-based Stent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nitinol-based Stent Sale Price by Type (2018-2023)
2.4 Nitinol-based Stent Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Nitinol-based Stent Sales by Application
2.5.1 Global Nitinol-based Stent Sale Market Share by Application (2018-2023)
2.5.2 Global Nitinol-based Stent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nitinol-based Stent Sale Price by Application (2018-2023)
3 GLOBAL NITINOL-BASED STENT BY COMPANY
3.1 Global Nitinol-based Stent Breakdown Data by Company
3.1.1 Global Nitinol-based Stent Annual Sales by Company (2018-2023)
3.1.2 Global Nitinol-based Stent Sales Market Share by Company (2018-2023)
3.2 Global Nitinol-based Stent Annual Revenue by Company (2018-2023)
3.2.1 Global Nitinol-based Stent Revenue by Company (2018-2023)
3.2.2 Global Nitinol-based Stent Revenue Market Share by Company (2018-2023)
3.3 Global Nitinol-based Stent Sale Price by Company
3.4 Key Manufacturers Nitinol-based Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nitinol-based Stent Product Location Distribution
3.4.2 Players Nitinol-based Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NITINOL-BASED STENT BY GEOGRAPHIC REGION
4.1 World Historic Nitinol-based Stent Market Size by Geographic Region (2018-2023)
4.1.1 Global Nitinol-based Stent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nitinol-based Stent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nitinol-based Stent Market Size by Country/Region (2018-2023)
4.2.1 Global Nitinol-based Stent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nitinol-based Stent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nitinol-based Stent Sales Growth
4.4 APAC Nitinol-based Stent Sales Growth
4.5 Europe Nitinol-based Stent Sales Growth
4.6 Middle East & Africa Nitinol-based Stent Sales Growth
5 AMERICAS
5.1 Americas Nitinol-based Stent Sales by Country
5.1.1 Americas Nitinol-based Stent Sales by Country (2018-2023)
5.1.2 Americas Nitinol-based Stent Revenue by Country (2018-2023)
5.2 Americas Nitinol-based Stent Sales by Type
5.3 Americas Nitinol-based Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nitinol-based Stent Sales by Region
6.1.1 APAC Nitinol-based Stent Sales by Region (2018-2023)
6.1.2 APAC Nitinol-based Stent Revenue by Region (2018-2023)
6.2 APAC Nitinol-based Stent Sales by Type
6.3 APAC Nitinol-based Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nitinol-based Stent by Country
7.1.1 Europe Nitinol-based Stent Sales by Country (2018-2023)
7.1.2 Europe Nitinol-based Stent Revenue by Country (2018-2023)
7.2 Europe Nitinol-based Stent Sales by Type
7.3 Europe Nitinol-based Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nitinol-based Stent by Country
8.1.1 Middle East & Africa Nitinol-based Stent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nitinol-based Stent Revenue by Country (2018-2023)
8.2 Middle East & Africa Nitinol-based Stent Sales by Type
8.3 Middle East & Africa Nitinol-based Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nitinol-based Stent
10.3 Manufacturing Process Analysis of Nitinol-based Stent
10.4 Industry Chain Structure of Nitinol-based Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nitinol-based Stent Distributors
11.3 Nitinol-based Stent Customer
12 WORLD FORECAST REVIEW FOR NITINOL-BASED STENT BY GEOGRAPHIC REGION
12.1 Global Nitinol-based Stent Market Size Forecast by Region
12.1.1 Global Nitinol-based Stent Forecast by Region (2024-2029)
12.1.2 Global Nitinol-based Stent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nitinol-based Stent Forecast by Type
12.7 Global Nitinol-based Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Nitinol-based Stent Product Portfolios and Specifications
13.1.3 Medtronic Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Edwards Lifesciences
13.2.1 Edwards Lifesciences Company Information
13.2.2 Edwards Lifesciences Nitinol-based Stent Product Portfolios and Specifications
13.2.3 Edwards Lifesciences Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Edwards Lifesciences Main Business Overview
13.2.5 Edwards Lifesciences Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Nitinol-based Stent Product Portfolios and Specifications
13.3.3 Abbott Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Boston Scientific
13.4.1 Boston Scientific Company Information
13.4.2 Boston Scientific Nitinol-based Stent Product Portfolios and Specifications
13.4.3 Boston Scientific Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Main Business Overview
13.4.5 Boston Scientific Latest Developments
13.5 TERUMO
13.5.1 TERUMO Company Information
13.5.2 TERUMO Nitinol-based Stent Product Portfolios and Specifications
13.5.3 TERUMO Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TERUMO Main Business Overview
13.5.5 TERUMO Latest Developments
13.6 C. R. Bard
13.6.1 C. R. Bard Company Information
13.6.2 C. R. Bard Nitinol-based Stent Product Portfolios and Specifications
13.6.3 C. R. Bard Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 C. R. Bard Main Business Overview
13.6.5 C. R. Bard Latest Developments
13.7 Cordis
13.7.1 Cordis Company Information
13.7.2 Cordis Nitinol-based Stent Product Portfolios and Specifications
13.7.3 Cordis Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cordis Main Business Overview
13.7.5 Cordis Latest Developments
13.8 Cook Medical
13.8.1 Cook Medical Company Information
13.8.2 Cook Medical Nitinol-based Stent Product Portfolios and Specifications
13.8.3 Cook Medical Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cook Medical Main Business Overview
13.8.5 Cook Medical Latest Developments
13.9 B. Braun
13.9.1 B. Braun Company Information
13.9.2 B. Braun Nitinol-based Stent Product Portfolios and Specifications
13.9.3 B. Braun Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 B. Braun Main Business Overview
13.9.5 B. Braun Latest Developments
13.10 Biotronik
13.10.1 Biotronik Company Information
13.10.2 Biotronik Nitinol-based Stent Product Portfolios and Specifications
13.10.3 Biotronik Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biotronik Main Business Overview
13.10.5 Biotronik Latest Developments
13.11 Stryker
13.11.1 Stryker Company Information
13.11.2 Stryker Nitinol-based Stent Product Portfolios and Specifications
13.11.3 Stryker Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Stryker Main Business Overview
13.11.5 Stryker Latest Developments
13.12 JOTEC
13.12.1 JOTEC Company Information
13.12.2 JOTEC Nitinol-based Stent Product Portfolios and Specifications
13.12.3 JOTEC Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 JOTEC Main Business Overview
13.12.5 JOTEC Latest Developments
13.13 MicroPort
13.13.1 MicroPort Company Information
13.13.2 MicroPort Nitinol-based Stent Product Portfolios and Specifications
13.13.3 MicroPort Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MicroPort Main Business Overview
13.13.5 MicroPort Latest Developments
13.14 Acandis
13.14.1 Acandis Company Information
13.14.2 Acandis Nitinol-based Stent Product Portfolios and Specifications
13.14.3 Acandis Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Acandis Main Business Overview
13.14.5 Acandis Latest Developments
13.15 ELLA-CS
13.15.1 ELLA-CS Company Information
13.15.2 ELLA-CS Nitinol-based Stent Product Portfolios and Specifications
13.15.3 ELLA-CS Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 ELLA-CS Main Business Overview
13.15.5 ELLA-CS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nitinol-based Stent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nitinol-based Stent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nitinol-based Stent by Country/Region, 2018, 2022 & 2029
2.2 Nitinol-based Stent Segment by Type
2.2.1 Bare-metal Stent (BMS)
2.2.2 Drug-eluting Stent (DES)
2.3 Nitinol-based Stent Sales by Type
2.3.1 Global Nitinol-based Stent Sales Market Share by Type (2018-2023)
2.3.2 Global Nitinol-based Stent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nitinol-based Stent Sale Price by Type (2018-2023)
2.4 Nitinol-based Stent Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Nitinol-based Stent Sales by Application
2.5.1 Global Nitinol-based Stent Sale Market Share by Application (2018-2023)
2.5.2 Global Nitinol-based Stent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nitinol-based Stent Sale Price by Application (2018-2023)
3 GLOBAL NITINOL-BASED STENT BY COMPANY
3.1 Global Nitinol-based Stent Breakdown Data by Company
3.1.1 Global Nitinol-based Stent Annual Sales by Company (2018-2023)
3.1.2 Global Nitinol-based Stent Sales Market Share by Company (2018-2023)
3.2 Global Nitinol-based Stent Annual Revenue by Company (2018-2023)
3.2.1 Global Nitinol-based Stent Revenue by Company (2018-2023)
3.2.2 Global Nitinol-based Stent Revenue Market Share by Company (2018-2023)
3.3 Global Nitinol-based Stent Sale Price by Company
3.4 Key Manufacturers Nitinol-based Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nitinol-based Stent Product Location Distribution
3.4.2 Players Nitinol-based Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NITINOL-BASED STENT BY GEOGRAPHIC REGION
4.1 World Historic Nitinol-based Stent Market Size by Geographic Region (2018-2023)
4.1.1 Global Nitinol-based Stent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nitinol-based Stent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nitinol-based Stent Market Size by Country/Region (2018-2023)
4.2.1 Global Nitinol-based Stent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nitinol-based Stent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nitinol-based Stent Sales Growth
4.4 APAC Nitinol-based Stent Sales Growth
4.5 Europe Nitinol-based Stent Sales Growth
4.6 Middle East & Africa Nitinol-based Stent Sales Growth
5 AMERICAS
5.1 Americas Nitinol-based Stent Sales by Country
5.1.1 Americas Nitinol-based Stent Sales by Country (2018-2023)
5.1.2 Americas Nitinol-based Stent Revenue by Country (2018-2023)
5.2 Americas Nitinol-based Stent Sales by Type
5.3 Americas Nitinol-based Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nitinol-based Stent Sales by Region
6.1.1 APAC Nitinol-based Stent Sales by Region (2018-2023)
6.1.2 APAC Nitinol-based Stent Revenue by Region (2018-2023)
6.2 APAC Nitinol-based Stent Sales by Type
6.3 APAC Nitinol-based Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nitinol-based Stent by Country
7.1.1 Europe Nitinol-based Stent Sales by Country (2018-2023)
7.1.2 Europe Nitinol-based Stent Revenue by Country (2018-2023)
7.2 Europe Nitinol-based Stent Sales by Type
7.3 Europe Nitinol-based Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nitinol-based Stent by Country
8.1.1 Middle East & Africa Nitinol-based Stent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nitinol-based Stent Revenue by Country (2018-2023)
8.2 Middle East & Africa Nitinol-based Stent Sales by Type
8.3 Middle East & Africa Nitinol-based Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nitinol-based Stent
10.3 Manufacturing Process Analysis of Nitinol-based Stent
10.4 Industry Chain Structure of Nitinol-based Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nitinol-based Stent Distributors
11.3 Nitinol-based Stent Customer
12 WORLD FORECAST REVIEW FOR NITINOL-BASED STENT BY GEOGRAPHIC REGION
12.1 Global Nitinol-based Stent Market Size Forecast by Region
12.1.1 Global Nitinol-based Stent Forecast by Region (2024-2029)
12.1.2 Global Nitinol-based Stent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nitinol-based Stent Forecast by Type
12.7 Global Nitinol-based Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Nitinol-based Stent Product Portfolios and Specifications
13.1.3 Medtronic Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Edwards Lifesciences
13.2.1 Edwards Lifesciences Company Information
13.2.2 Edwards Lifesciences Nitinol-based Stent Product Portfolios and Specifications
13.2.3 Edwards Lifesciences Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Edwards Lifesciences Main Business Overview
13.2.5 Edwards Lifesciences Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Nitinol-based Stent Product Portfolios and Specifications
13.3.3 Abbott Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Boston Scientific
13.4.1 Boston Scientific Company Information
13.4.2 Boston Scientific Nitinol-based Stent Product Portfolios and Specifications
13.4.3 Boston Scientific Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Main Business Overview
13.4.5 Boston Scientific Latest Developments
13.5 TERUMO
13.5.1 TERUMO Company Information
13.5.2 TERUMO Nitinol-based Stent Product Portfolios and Specifications
13.5.3 TERUMO Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TERUMO Main Business Overview
13.5.5 TERUMO Latest Developments
13.6 C. R. Bard
13.6.1 C. R. Bard Company Information
13.6.2 C. R. Bard Nitinol-based Stent Product Portfolios and Specifications
13.6.3 C. R. Bard Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 C. R. Bard Main Business Overview
13.6.5 C. R. Bard Latest Developments
13.7 Cordis
13.7.1 Cordis Company Information
13.7.2 Cordis Nitinol-based Stent Product Portfolios and Specifications
13.7.3 Cordis Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cordis Main Business Overview
13.7.5 Cordis Latest Developments
13.8 Cook Medical
13.8.1 Cook Medical Company Information
13.8.2 Cook Medical Nitinol-based Stent Product Portfolios and Specifications
13.8.3 Cook Medical Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cook Medical Main Business Overview
13.8.5 Cook Medical Latest Developments
13.9 B. Braun
13.9.1 B. Braun Company Information
13.9.2 B. Braun Nitinol-based Stent Product Portfolios and Specifications
13.9.3 B. Braun Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 B. Braun Main Business Overview
13.9.5 B. Braun Latest Developments
13.10 Biotronik
13.10.1 Biotronik Company Information
13.10.2 Biotronik Nitinol-based Stent Product Portfolios and Specifications
13.10.3 Biotronik Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biotronik Main Business Overview
13.10.5 Biotronik Latest Developments
13.11 Stryker
13.11.1 Stryker Company Information
13.11.2 Stryker Nitinol-based Stent Product Portfolios and Specifications
13.11.3 Stryker Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Stryker Main Business Overview
13.11.5 Stryker Latest Developments
13.12 JOTEC
13.12.1 JOTEC Company Information
13.12.2 JOTEC Nitinol-based Stent Product Portfolios and Specifications
13.12.3 JOTEC Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 JOTEC Main Business Overview
13.12.5 JOTEC Latest Developments
13.13 MicroPort
13.13.1 MicroPort Company Information
13.13.2 MicroPort Nitinol-based Stent Product Portfolios and Specifications
13.13.3 MicroPort Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MicroPort Main Business Overview
13.13.5 MicroPort Latest Developments
13.14 Acandis
13.14.1 Acandis Company Information
13.14.2 Acandis Nitinol-based Stent Product Portfolios and Specifications
13.14.3 Acandis Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Acandis Main Business Overview
13.14.5 Acandis Latest Developments
13.15 ELLA-CS
13.15.1 ELLA-CS Company Information
13.15.2 ELLA-CS Nitinol-based Stent Product Portfolios and Specifications
13.15.3 ELLA-CS Nitinol-based Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 ELLA-CS Main Business Overview
13.15.5 ELLA-CS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nitinol-based Stent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nitinol-based Stent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bare-metal Stent (BMS)
Table 4. Major Players of Drug-eluting Stent (DES)
Table 5. Global Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 6. Global Nitinol-based Stent Sales Market Share by Type (2018-2023)
Table 7. Global Nitinol-based Stent Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nitinol-based Stent Revenue Market Share by Type (2018-2023)
Table 9. Global Nitinol-based Stent Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 11. Global Nitinol-based Stent Sales Market Share by Application (2018-2023)
Table 12. Global Nitinol-based Stent Revenue by Application (2018-2023)
Table 13. Global Nitinol-based Stent Revenue Market Share by Application (2018-2023)
Table 14. Global Nitinol-based Stent Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Nitinol-based Stent Sales by Company (2018-2023) & (K Units)
Table 16. Global Nitinol-based Stent Sales Market Share by Company (2018-2023)
Table 17. Global Nitinol-based Stent Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nitinol-based Stent Revenue Market Share by Company (2018-2023)
Table 19. Global Nitinol-based Stent Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Nitinol-based Stent Producing Area Distribution and Sales Area
Table 21. Players Nitinol-based Stent Products Offered
Table 22. Nitinol-based Stent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nitinol-based Stent Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Nitinol-based Stent Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nitinol-based Stent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nitinol-based Stent Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nitinol-based Stent Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Nitinol-based Stent Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nitinol-based Stent Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nitinol-based Stent Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 34. Americas Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 35. Americas Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 37. Americas Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 38. Americas Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 39. APAC Nitinol-based Stent Sales by Region (2018-2023) & (K Units)
Table 40. APAC Nitinol-based Stent Sales Market Share by Region (2018-2023)
Table 41. APAC Nitinol-based Stent Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nitinol-based Stent Revenue Market Share by Region (2018-2023)
Table 43. APAC Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 44. APAC Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 45. Europe Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 46. Europe Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 47. Europe Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 49. Europe Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 50. Europe Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nitinol-based Stent
Table 58. Key Market Challenges & Risks of Nitinol-based Stent
Table 59. Key Industry Trends of Nitinol-based Stent
Table 60. Nitinol-based Stent Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nitinol-based Stent Distributors List
Table 63. Nitinol-based Stent Customer List
Table 64. Global Nitinol-based Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Nitinol-based Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nitinol-based Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Nitinol-based Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nitinol-based Stent Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Nitinol-based Stent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nitinol-based Stent Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Nitinol-based Stent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Nitinol-based Stent Product Portfolios and Specifications
Table 80. Medtronic Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Edwards Lifesciences Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 84. Edwards Lifesciences Nitinol-based Stent Product Portfolios and Specifications
Table 85. Edwards Lifesciences Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Edwards Lifesciences Main Business
Table 87. Edwards Lifesciences Latest Developments
Table 88. Abbott Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Nitinol-based Stent Product Portfolios and Specifications
Table 90. Abbott Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Boston Scientific Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Nitinol-based Stent Product Portfolios and Specifications
Table 95. Boston Scientific Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. TERUMO Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 99. TERUMO Nitinol-based Stent Product Portfolios and Specifications
Table 100. TERUMO Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. TERUMO Main Business
Table 102. TERUMO Latest Developments
Table 103. C. R. Bard Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 104. C. R. Bard Nitinol-based Stent Product Portfolios and Specifications
Table 105. C. R. Bard Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. C. R. Bard Main Business
Table 107. C. R. Bard Latest Developments
Table 108. Cordis Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 109. Cordis Nitinol-based Stent Product Portfolios and Specifications
Table 110. Cordis Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Cordis Main Business
Table 112. Cordis Latest Developments
Table 113. Cook Medical Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 114. Cook Medical Nitinol-based Stent Product Portfolios and Specifications
Table 115. Cook Medical Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Cook Medical Main Business
Table 117. Cook Medical Latest Developments
Table 118. B. Braun Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 119. B. Braun Nitinol-based Stent Product Portfolios and Specifications
Table 120. B. Braun Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. B. Braun Main Business
Table 122. B. Braun Latest Developments
Table 123. Biotronik Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 124. Biotronik Nitinol-based Stent Product Portfolios and Specifications
Table 125. Biotronik Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Biotronik Main Business
Table 127. Biotronik Latest Developments
Table 128. Stryker Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 129. Stryker Nitinol-based Stent Product Portfolios and Specifications
Table 130. Stryker Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Stryker Main Business
Table 132. Stryker Latest Developments
Table 133. JOTEC Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 134. JOTEC Nitinol-based Stent Product Portfolios and Specifications
Table 135. JOTEC Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. JOTEC Main Business
Table 137. JOTEC Latest Developments
Table 138. MicroPort Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 139. MicroPort Nitinol-based Stent Product Portfolios and Specifications
Table 140. MicroPort Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. MicroPort Main Business
Table 142. MicroPort Latest Developments
Table 143. Acandis Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 144. Acandis Nitinol-based Stent Product Portfolios and Specifications
Table 145. Acandis Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Acandis Main Business
Table 147. Acandis Latest Developments
Table 148. ELLA-CS Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 149. ELLA-CS Nitinol-based Stent Product Portfolios and Specifications
Table 150. ELLA-CS Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. ELLA-CS Main Business
Table 152. ELLA-CS Latest Developments
Table 1. Nitinol-based Stent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nitinol-based Stent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bare-metal Stent (BMS)
Table 4. Major Players of Drug-eluting Stent (DES)
Table 5. Global Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 6. Global Nitinol-based Stent Sales Market Share by Type (2018-2023)
Table 7. Global Nitinol-based Stent Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nitinol-based Stent Revenue Market Share by Type (2018-2023)
Table 9. Global Nitinol-based Stent Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 11. Global Nitinol-based Stent Sales Market Share by Application (2018-2023)
Table 12. Global Nitinol-based Stent Revenue by Application (2018-2023)
Table 13. Global Nitinol-based Stent Revenue Market Share by Application (2018-2023)
Table 14. Global Nitinol-based Stent Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Nitinol-based Stent Sales by Company (2018-2023) & (K Units)
Table 16. Global Nitinol-based Stent Sales Market Share by Company (2018-2023)
Table 17. Global Nitinol-based Stent Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nitinol-based Stent Revenue Market Share by Company (2018-2023)
Table 19. Global Nitinol-based Stent Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Nitinol-based Stent Producing Area Distribution and Sales Area
Table 21. Players Nitinol-based Stent Products Offered
Table 22. Nitinol-based Stent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nitinol-based Stent Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Nitinol-based Stent Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nitinol-based Stent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nitinol-based Stent Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nitinol-based Stent Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Nitinol-based Stent Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nitinol-based Stent Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nitinol-based Stent Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 34. Americas Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 35. Americas Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 37. Americas Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 38. Americas Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 39. APAC Nitinol-based Stent Sales by Region (2018-2023) & (K Units)
Table 40. APAC Nitinol-based Stent Sales Market Share by Region (2018-2023)
Table 41. APAC Nitinol-based Stent Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nitinol-based Stent Revenue Market Share by Region (2018-2023)
Table 43. APAC Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 44. APAC Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 45. Europe Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 46. Europe Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 47. Europe Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 49. Europe Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 50. Europe Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Nitinol-based Stent Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nitinol-based Stent Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nitinol-based Stent Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nitinol-based Stent Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Nitinol-based Stent Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nitinol-based Stent
Table 58. Key Market Challenges & Risks of Nitinol-based Stent
Table 59. Key Industry Trends of Nitinol-based Stent
Table 60. Nitinol-based Stent Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nitinol-based Stent Distributors List
Table 63. Nitinol-based Stent Customer List
Table 64. Global Nitinol-based Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Nitinol-based Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nitinol-based Stent Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Nitinol-based Stent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nitinol-based Stent Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Nitinol-based Stent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nitinol-based Stent Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Nitinol-based Stent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nitinol-based Stent Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Nitinol-based Stent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Nitinol-based Stent Product Portfolios and Specifications
Table 80. Medtronic Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Edwards Lifesciences Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 84. Edwards Lifesciences Nitinol-based Stent Product Portfolios and Specifications
Table 85. Edwards Lifesciences Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Edwards Lifesciences Main Business
Table 87. Edwards Lifesciences Latest Developments
Table 88. Abbott Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Nitinol-based Stent Product Portfolios and Specifications
Table 90. Abbott Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Boston Scientific Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Nitinol-based Stent Product Portfolios and Specifications
Table 95. Boston Scientific Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. TERUMO Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 99. TERUMO Nitinol-based Stent Product Portfolios and Specifications
Table 100. TERUMO Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. TERUMO Main Business
Table 102. TERUMO Latest Developments
Table 103. C. R. Bard Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 104. C. R. Bard Nitinol-based Stent Product Portfolios and Specifications
Table 105. C. R. Bard Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. C. R. Bard Main Business
Table 107. C. R. Bard Latest Developments
Table 108. Cordis Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 109. Cordis Nitinol-based Stent Product Portfolios and Specifications
Table 110. Cordis Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Cordis Main Business
Table 112. Cordis Latest Developments
Table 113. Cook Medical Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 114. Cook Medical Nitinol-based Stent Product Portfolios and Specifications
Table 115. Cook Medical Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Cook Medical Main Business
Table 117. Cook Medical Latest Developments
Table 118. B. Braun Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 119. B. Braun Nitinol-based Stent Product Portfolios and Specifications
Table 120. B. Braun Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. B. Braun Main Business
Table 122. B. Braun Latest Developments
Table 123. Biotronik Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 124. Biotronik Nitinol-based Stent Product Portfolios and Specifications
Table 125. Biotronik Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Biotronik Main Business
Table 127. Biotronik Latest Developments
Table 128. Stryker Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 129. Stryker Nitinol-based Stent Product Portfolios and Specifications
Table 130. Stryker Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Stryker Main Business
Table 132. Stryker Latest Developments
Table 133. JOTEC Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 134. JOTEC Nitinol-based Stent Product Portfolios and Specifications
Table 135. JOTEC Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. JOTEC Main Business
Table 137. JOTEC Latest Developments
Table 138. MicroPort Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 139. MicroPort Nitinol-based Stent Product Portfolios and Specifications
Table 140. MicroPort Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. MicroPort Main Business
Table 142. MicroPort Latest Developments
Table 143. Acandis Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 144. Acandis Nitinol-based Stent Product Portfolios and Specifications
Table 145. Acandis Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Acandis Main Business
Table 147. Acandis Latest Developments
Table 148. ELLA-CS Basic Information, Nitinol-based Stent Manufacturing Base, Sales Area and Its Competitors
Table 149. ELLA-CS Nitinol-based Stent Product Portfolios and Specifications
Table 150. ELLA-CS Nitinol-based Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. ELLA-CS Main Business
Table 152. ELLA-CS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nitinol-based Stent
Figure 2. Nitinol-based Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nitinol-based Stent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nitinol-based Stent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nitinol-based Stent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bare-metal Stent (BMS)
Figure 10. Product Picture of Drug-eluting Stent (DES)
Figure 11. Global Nitinol-based Stent Sales Market Share by Type in 2022
Figure 12. Global Nitinol-based Stent Revenue Market Share by Type (2018-2023)
Figure 13. Nitinol-based Stent Consumed in Hospital
Figure 14. Global Nitinol-based Stent Market: Hospital (2018-2023) & (K Units)
Figure 15. Nitinol-based Stent Consumed in Clinics
Figure 16. Global Nitinol-based Stent Market: Clinics (2018-2023) & (K Units)
Figure 17. Nitinol-based Stent Consumed in Other
Figure 18. Global Nitinol-based Stent Market: Other (2018-2023) & (K Units)
Figure 19. Global Nitinol-based Stent Sales Market Share by Application (2022)
Figure 20. Global Nitinol-based Stent Revenue Market Share by Application in 2022
Figure 21. Nitinol-based Stent Sales Market by Company in 2022 (K Units)
Figure 22. Global Nitinol-based Stent Sales Market Share by Company in 2022
Figure 23. Nitinol-based Stent Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Nitinol-based Stent Revenue Market Share by Company in 2022
Figure 25. Global Nitinol-based Stent Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Nitinol-based Stent Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 28. Americas Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 29. APAC Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 30. APAC Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 31. Europe Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 32. Europe Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 35. Americas Nitinol-based Stent Sales Market Share by Country in 2022
Figure 36. Americas Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 37. Americas Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 38. Americas Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 39. United States Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Nitinol-based Stent Sales Market Share by Region in 2022
Figure 44. APAC Nitinol-based Stent Revenue Market Share by Regions in 2022
Figure 45. APAC Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 46. APAC Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 47. China Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Nitinol-based Stent Sales Market Share by Country in 2022
Figure 55. Europe Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 56. Europe Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 57. Europe Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 58. Germany Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Nitinol-based Stent Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 67. Egypt Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nitinol-based Stent in 2022
Figure 73. Manufacturing Process Analysis of Nitinol-based Stent
Figure 74. Industry Chain Structure of Nitinol-based Stent
Figure 75. Channels of Distribution
Figure 76. Global Nitinol-based Stent Sales Market Forecast by Region (2024-2029)
Figure 77. Global Nitinol-based Stent Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Nitinol-based Stent Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Nitinol-based Stent Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Nitinol-based Stent Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Nitinol-based Stent Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Nitinol-based Stent
Figure 2. Nitinol-based Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nitinol-based Stent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nitinol-based Stent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nitinol-based Stent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bare-metal Stent (BMS)
Figure 10. Product Picture of Drug-eluting Stent (DES)
Figure 11. Global Nitinol-based Stent Sales Market Share by Type in 2022
Figure 12. Global Nitinol-based Stent Revenue Market Share by Type (2018-2023)
Figure 13. Nitinol-based Stent Consumed in Hospital
Figure 14. Global Nitinol-based Stent Market: Hospital (2018-2023) & (K Units)
Figure 15. Nitinol-based Stent Consumed in Clinics
Figure 16. Global Nitinol-based Stent Market: Clinics (2018-2023) & (K Units)
Figure 17. Nitinol-based Stent Consumed in Other
Figure 18. Global Nitinol-based Stent Market: Other (2018-2023) & (K Units)
Figure 19. Global Nitinol-based Stent Sales Market Share by Application (2022)
Figure 20. Global Nitinol-based Stent Revenue Market Share by Application in 2022
Figure 21. Nitinol-based Stent Sales Market by Company in 2022 (K Units)
Figure 22. Global Nitinol-based Stent Sales Market Share by Company in 2022
Figure 23. Nitinol-based Stent Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Nitinol-based Stent Revenue Market Share by Company in 2022
Figure 25. Global Nitinol-based Stent Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Nitinol-based Stent Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 28. Americas Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 29. APAC Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 30. APAC Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 31. Europe Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 32. Europe Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Nitinol-based Stent Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Nitinol-based Stent Revenue 2018-2023 ($ Millions)
Figure 35. Americas Nitinol-based Stent Sales Market Share by Country in 2022
Figure 36. Americas Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 37. Americas Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 38. Americas Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 39. United States Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Nitinol-based Stent Sales Market Share by Region in 2022
Figure 44. APAC Nitinol-based Stent Revenue Market Share by Regions in 2022
Figure 45. APAC Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 46. APAC Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 47. China Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Nitinol-based Stent Sales Market Share by Country in 2022
Figure 55. Europe Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 56. Europe Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 57. Europe Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 58. Germany Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Nitinol-based Stent Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Nitinol-based Stent Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Nitinol-based Stent Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Nitinol-based Stent Sales Market Share by Application (2018-2023)
Figure 67. Egypt Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Nitinol-based Stent Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Nitinol-based Stent in 2022
Figure 73. Manufacturing Process Analysis of Nitinol-based Stent
Figure 74. Industry Chain Structure of Nitinol-based Stent
Figure 75. Channels of Distribution
Figure 76. Global Nitinol-based Stent Sales Market Forecast by Region (2024-2029)
Figure 77. Global Nitinol-based Stent Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Nitinol-based Stent Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Nitinol-based Stent Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Nitinol-based Stent Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Nitinol-based Stent Revenue Market Share Forecast by Application (2024-2029)
